Physiotherapy Department, Faculty of Health Sciences, European University of Gasteiz-EUNEIZ, La Biosfera Ibilbidea, 6, 01013 Vitoria-Gasteiz, Spain.
Faculty of Medicine and Health Sciences, Universitat Internacional de Catalunya (UIC-Barcelona), C/Josep Trueta s/n, 08017 Sant Cugat del Vallès, Spain.
Int J Environ Res Public Health. 2022 Dec 10;19(24):16619. doi: 10.3390/ijerph192416619.
The worldwide pandemic caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) virus has impacted all healthcare systems. One potential sequela experienced by hospitalized coronavirus disease 2019 (COVID-19) survivors includes muscle weakness with a reduction in strength and, consequently, a possible increase in frailty. The aim of this clinical trial was to evaluate the efficacy of adding an online therapeutic exercise program for 8 weeks to the medical prescriptions on functional variables in patients hospitalized due to COVID-19. A randomized controlled trial including 70 previously hospitalized COVID-19 survivors was conducted. Patients were randomly allocated to an experimental (n = 35) or control (n = 35) group. Both groups received regular prescriptions provided by their medical doctors. The experimental group also received a live online therapeutic exercise program for 8 weeks (3 sessions/week). Handgrip strength, gait speed, lower-extremity strength, balance, and frailty were assessed at baseline, at the end of the program, and one month after the end of the intervention. The repeated measures analysis of variance revealed significant Group*Time interactions for all the outcomes: (handgrip dominant: F = 17.395, < 0.001, η = 0.24; handgrip non-dominant: F = 33.197, < 0.001, η = 0.33; 4 m walk test (4WT): F = 13.039, = 0.001, η = 0.16; short physical performance battery (SPPB): F = 26.421, < 0.001, η = 0.28; the five chair-raise test (5CRT): F = 5.628, = 0.004, η = 0.08; FRAIL scale: F = 11.249, = 0.001, η = 0.14): patients in the experimental group experienced greater improvements in all outcomes than those assigned to the control group. This study revealed that the addition of an online exercise program for 8 weeks obtained greater improvements in handgrip strength, gait speed, lower-extremity strength, balance, and frailty in a sample of previously hospitalized COVID-19 survivors than application of just usual medical prescription.
由严重急性呼吸综合征冠状病毒 2(SARS-CoV-2)病毒引起的全球大流行影响了所有的医疗保健系统。住院的 2019 年冠状病毒病(COVID-19)幸存者中可能出现的一种后遗症是肌肉无力,导致力量下降,进而可能导致虚弱增加。本临床试验的目的是评估在因 COVID-19 住院的患者的医疗处方中添加 8 周在线治疗性运动方案对功能变量的疗效。进行了一项包括 70 名先前住院 COVID-19 幸存者的随机对照试验。患者被随机分配到实验组(n = 35)或对照组(n = 35)。两组均接受其医生提供的常规处方。实验组还接受了为期 8 周的现场在线治疗性运动方案(每周 3 次)。在基线、方案结束时和干预结束后 1 个月评估握力、步态速度、下肢力量、平衡和虚弱程度。重复测量方差分析显示,所有结局的组*时间交互作用均具有统计学意义:(优势手握力:F = 17.395,< 0.001,η = 0.24;非优势手握力:F = 33.197,< 0.001,η = 0.33;4 米步行测试(4WT):F = 13.039,= 0.001,η = 0.16;简短体能测试(SPPB):F = 26.421,< 0.001,η = 0.28;五椅站立测试(5CRT):F = 5.628,= 0.004,η = 0.08;脆弱性量表(FRAIL):F = 11.249,= 0.001,η = 0.14):实验组患者在所有结局上的改善均大于对照组患者。这项研究表明,在因 COVID-19 住院的幸存者样本中,添加 8 周的在线运动方案比仅应用常规医疗处方能获得更大的握力、步态速度、下肢力量、平衡和虚弱程度改善。